Project Number 3R01AG057658-03S1 Agency/Funding Organization NIA Funding Year 2020 View Full Project Details for Treating Alzheimer's disease by reducing brain insulin resistance with incretin receptor agonists Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) j. Metabolism and Bioenergetics Researcher and Organization Principal Investigator TALBOT, KONRAD Principal Investigator First Name KONRAD Principal Investigator Last Name TALBOT Awardee Organization LOMA LINDA UNIVERSITY Awardee State California Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-16-041: DRUG DISCOVERY FOR NERVOUS SYSTEM DISORDERS (R01) FY Overall Cost $54,500 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official REFOLO, LORENZO
